{
    "pmcid": "11148769",
    "qa_pairs": {
        "What does the study identify as affecting the binding efficacy of nanobodies to the SARS-CoV-2 spike protein?": [
            "Specific mutations in the RBD.",
            "Variations in the spike protein's overall size.",
            "Changes in the spike protein's glycosylation patterns.",
            "Alterations in the spike protein's lipid composition."
        ],
        "What does the study suggest about the potential for nanobody engineering against SARS-CoV-2 variants?": [
            "Nanobodies can be engineered to target conserved regions of the spike protein for broad-spectrum neutralization.",
            "Nanobodies can be engineered to increase their size for better binding.",
            "Nanobodies can be engineered to decrease their production cost.",
            "Nanobodies can be engineered to reduce their affinity for the ACE2 receptor."
        ],
        "What is emphasized as a future direction for nanobody research in combating SARS-CoV-2?": [
            "Optimizing nanobody design to enhance stability, affinity, and breadth of neutralization.",
            "Increasing the molecular weight of nanobodies for better efficacy.",
            "Reducing the production time of nanobodies to meet demand.",
            "Focusing on single-site targeting to simplify nanobody interactions."
        ],
        "What is one of the key advantages of nanobodies over traditional antibodies in therapeutic applications against SARS-CoV-2?": [
            "Nanobodies have a smaller size, allowing them to penetrate tissues more effectively.",
            "Nanobodies have a higher molecular weight, which enhances their stability.",
            "Nanobodies are more expensive to produce, increasing their market value.",
            "Nanobodies have a longer half-life in the bloodstream, reducing dosing frequency."
        ],
        "Which specific complex involving nanobodies is mentioned in the structural analysis of SARS-CoV-2 spike protein interactions?": [
            "Delta-RBD/XBB-2/NbC1 complex",
            "Alpha-RBD/YBB-1/NbA2 complex",
            "Gamma-RBD/ZBB-3/NbB3 complex",
            "Beta-RBD/WBB-4/NbD4 complex"
        ]
    }
}